Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study
Background: Despite the increasing interest in biologics for the management of allergic diseases, sparse real-world data are still available in the pediatric population. This study aimed to evaluate the early real-life efficacy and safety of omalizumab for patients with moderate-to-severe asthma and...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | 英语 |
| 出版: |
2024
|
| 在線閱讀: | https://doi.org/10.3390/children11020170 https://www.mdpi.com/2227-9067/11/2/170/pdf?version=1706432217 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|